Eagle Pharmaceuticals, Inc.: SCHEDULE 13G filed Feb 19, 2025

Form type

SCHEDULE 13G

Filing date

Feb 19, 2025

Accession number

0001104659-25-015192

Filer

Eagle Pharmaceuticals, Inc. (CIK 827871)